We also provide consulting services for the target-to-hit phase and structurally-enabled campaigns. Our cutting-edge solutions, collaborative culture, speed and agility, enable us to move with you in the direction, that will best suit your quest for success.
Fragment-based drug design relies heavily on the availability of structural data for fragment growth into a lead candidate. Based on our track record in structural biology, we can support your campaigns by applying our proprietary know-how for de-risking the projects. For example, not every crystal packing is suitable for co-structure determination by X-ray crystallography. We offer packing analyses and soakability assessments to ensure the compatibility of the crystals and ligands for co-structure determination.
Our spectrum of expertise also covers covalent and non-covalent strategies and library design for structurally-enabled screening and drug discovery campaigns.
